The combined effect of environmental exposures and unhealthy lifestyle habits can affect children’s cardiometabolic health in a way that exceeds their separate effects.
FDA approves Novartis drug for rare blood disorder
The FDA has approved Novartis’ pill iptacopan for adults with paroxysmal nocturnal hemoglobinuria, or PNH, a rare disorder where the red blood cells break up